INS and type 2 diabetes mellitus: Alkharaiji et al.24examined high‐risk patients with advanced fibrosis and insulin‐treated T2D with a follow‐up of 5 years, which might be too short to demonstrate a beneficial impact of MBS, given the timeframe for fibrosis resolution after surgery.10